Brookings June 22, 2020
Rosalie Liccardo Pacula and Bradley D. Stein

EXECUTIVE SUMMARY

The breadth, depth, and dynamic evolution of the opioid crisis have left states exploring a plethora of strategies to reduce the supply, inappropriate use, and harm caused by prescription opioid analgesics and illicit opioids. While considerable research has focused on the impact of various supply strategies and prescribing practices, significant structural changes affecting the treatment of substance use disorder—enabled and advanced by states’ policy decisions—have received far less attention.

In this paper, we discuss three broad strategies states are taking, through a variety of policy levers, to enhance the quality of and access to treatment for opioid use disorder (OUD). The first and most well-known strategy involves increasing insurance coverage and payment for...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, States
Addressing Healthcare’s Retention Crisis by Understanding Gen Z
M&A Cyber Success Depends on Communication, an Honest Evaluation of Each Side’s Strengths & Risks, and an Open Mind
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
Dr. Amar Naik and Shrinking the Knowing/Doing Gap in GI Care
STAT+: Trump’s FDA director pick has a history of criticizing the agency. Here are seven examples

Share This Article